共 52 条
Risk factors for corticosteroid insufficiency during the sub-acute phase of acute traumatic brain injury
被引:8
作者:
Chen, Xin
[1
]
Chai, Yan
[2
,3
,4
]
Wang, Shao-Bo
[5
]
Wang, Jia-Chong
[6
]
Yue, Shu-Yuan
[1
]
Jiang, Rong-Cai
[1
]
Zhang, Jian-Ning
[2
,3
,4
]
机构:
[1] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China
[2] Tianjin Neurol Inst, Tianjin, Peoples R China
[3] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China
[4] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China
[5] Ordos Cent Hosp, Dept Neurosurg, Ordos, Inner Mongolia, Peoples R China
[6] Cent S Univ, Xiangya Med Coll, Affiliated Haikou Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China
基金:
中国国家自然科学基金;
关键词:
CARE MEDICINE SCCM;
CRITICAL-ILLNESS;
EUROPEAN-SOCIETY;
MANAGEMENT;
DIAGNOSIS;
GUIDELINES;
MECHANISM;
CIRRHOSIS;
CIRCI;
D O I:
10.4103/1673-5374.272611
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Hypothalamic-pituitary-adrenal axis dysfunction may lead to the occurrence of critical illness-related corticosteroid insufficiency. Critical illness-related corticosteroid insufficiency can easily occur after traumatic brain injury, but few studies have examined this occurrence. A multicenter, prospective, cohort study was performed to evaluate the function of the hypothalamic-pituitary-adrenal axis and the incidence of critical illness-related corticosteroid insufficiency during the sub-acute phase of traumatic brain injury. One hundred and forty patients with acute traumatic brain injury were enrolled from the neurosurgical departments of three tertiary-level hospitals in China, and the critical illness-related corticosteroid insufficiency incidence, critical-illness-related corticosteroid insufficiency-related risk factors, complications, and 28-day mortality among these patients was recorded. Critical illness-related corticosteroid insufficiency was diagnosed in patients with plasma total cortisol levels less than 10 mu g/dL (275.9 nM) on post-injury day 4 or when serum cortisol was insufficiently suppressed (less than 50%) during a dexamethasone suppression test on post-injury day 5. The results demonstrated that critical illness-related corticosteroid insufficiency occurred during the sub-acute phase of traumatic brain injury in 5.6% of patients with mild injury, 22.5% of patients with moderate injury, and 52.2% of patients with severe injury. Traumatic brain injury-induced critical illness-related corticosteroid insufficiency was strongly correlated to injury severity during the sub-acute stage of traumatic brain injury. Traumatic brain injury patients with critical illness-related corticosteroid insufficiency frequently presented with hemorrhagic cerebral contusions, diffuse axonal injury, brain herniation, and hypotension. Differences in the incidence of hospital-acquired pneumonia, gastrointestinal bleeding, and 28-day mortality were observed between patients with and without critical illness-related corticosteroid insufficiency during the sub-acute phase of traumatic brain injury. Hypotension, brain-injury severity, and the types of traumatic brain injury were independent risk factors for traumatic brain injury-induced critical illness-related corticosteroid insufficiency. These findings indicate that critical illness-related corticosteroid insufficiency is common during the sub-acute phase of traumatic brain injury and is strongly associated with poor prognosis. The dexamethasone suppression test is a practical assay for the evaluation of hypothalamic-pituitary-adrenal axis function and for the diagnosis of critical illness-related corticosteroid insufficiency in patients with traumatic brain injury, especially those with hypotension, hemorrhagic cerebral contusions, diffuse axonal injury, and brain herniation. Sub-acute infection of acute traumatic brain injury may be an important factor associated with the occurrence and development of critical illness-related corticosteroid insufficiency. This study protocol was approved by the Ethics Committee of General Hospital of Tianjin Medical University, China in December 2011 (approval No. 201189).
引用
收藏
页码:1259 / 1265
页数:7
相关论文